Clinical trials
Insulin Resistance trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 7 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Unknown status | 5 |
| Terminated | 4 |
| Withdrawn | 3 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karolinska Institutet | 12 |
| Lund University | 6 |
| Umeå University | 3 |
| University Hospital, Linkoeping | 3 |
| Uppsala University | 3 |
| Vastra Gotaland Region | 3 |
| AstraZeneca | 2 |
| Göteborg University | 2 |
| Karolinska University Hospital | 2 |
| Swedish University of Agricultural Sciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 50 |
| Diabetes Mellitus, Type 2 | 14 |
| Diabetes Mellitus | 9 |
| Obesity | 9 |
| Metabolic Syndrome | 5 |
| Hyperglycemia | 4 |
| Fatty Liver | 3 |
| Glucose Intolerance | 3 |
| Polycystic Ovary Syndrome | 3 |
| Cardiovascular Diseases | 2 |
Trials
Showing 26 to 50 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.